Aromatic chloride to nitrile transformation: medicinal and synthetic chemistry

This review highlights the medicinal and synthetic chemistry relevance of replacing an aromatic chloride motif with an aromatic nitrile. We explore the desirable features that this transformation can bring in a drug design sense and the recent synthetic chemistry advances that effect this replacement in a single step.

[1]  H. Alper,et al.  Transformations of Chloroarenes, Catalyzed by Transition-Metal Complexes , 1994 .

[2]  Melanie S Sanford,et al.  Palladium-catalyzed ligand-directed C-H functionalization reactions. , 2010, Chemical reviews.

[3]  P. Confalone,et al.  Palladium-catalyzed cyanation reactions of aryl chlorides , 2000 .

[4]  Weiliang Zhu,et al.  Nonbonding interactions of organic halogens in biological systems: implications for drug discovery and biomolecular design. , 2010, Physical chemistry chemical physics : PCCP.

[5]  Xiaohong Liu,et al.  Crystal structures of HIV-1 reverse transcriptase with etravirine (TMC125) and rilpivirine (TMC278): implications for drug design. , 2010, Journal of medicinal chemistry.

[6]  T. Okamoto,et al.  Nucleophilic Displacement Catalyzed by Transition Metal. III. Kinetic Investigation of the Cyanation of Iodobenzene Catalyzed by Palladium(II) , 1976 .

[7]  M. Beller,et al.  Increasing the Scope of Palladium-Catalyzed Cyanations of Aryl Chlorides , 2009 .

[8]  D. Kassel,et al.  Discovery of alogliptin: a potent, selective, bioavailable, and efficacious inhibitor of dipeptidyl peptidase IV. , 2007, Journal of medicinal chemistry.

[9]  C. Lipinski.  Drug-like properties and the causes of poor solubility and poor permeability. , 2000, Journal of pharmacological and toxicological methods.

[10]  J. Sangster.  Octanol-Water Partition Coefficients: Fundamentals and Physical Chemistry , 1997 .

[11]  P. Lam,et al.  Discovery of 1-(3'-aminobenzisoxazol-5'-yl)-3-trifluoromethyl-N-[2-fluoro-4- [(2'-dimethylaminomethyl)imidazol-1-yl]phenyl]-1H-pyrazole-5-carboxyamide hydrochloride (razaxaban), a highly potent, selective, and orally bioavailable factor Xa inhibitor. , 2005, Journal of medicinal chemistry.

[12]  Anja Palusczak,et al.  Synthesis and biological evaluation of 5-[(aryl)(1H-imidazol-1-yl)methyl]-1H-indoles: potent and selective aromatase inhibitors. , 2006, Bioorganic & medicinal chemistry letters.

[13]  J. D. de Vries,et al.  Homeopathic ligand-free palladium as a catalyst in the heck reaction. A comparison with a palladacycle. , 2003, Organic letters.

[14]  S. Buchwald,et al.  Catalysts for Suzuki-Miyaura coupling processes: scope and studies of the effect of ligand structure. , 2005, Journal of the American Chemical Society.

[15]  G. P. Ellis,et al.  Cyanation of aromatic halides , 1987 .

[16]  G. C. Fu,et al.  Palladium-catalyzed coupling reactions of aryl chlorides. , 2002, Angewandte Chemie.

[17]  John Whittall,et al.  Optimisation and scale-up of microwave assisted cyanation , 2006 .

[18]  M. Beller,et al.  Potassium hexacyanoferrate(II)--a new cyanating agent for the palladium-catalyzed cyanation of aryl halides. , 2004, Chemical communications.

[19]  M. Leskelä,et al.  Synthesis of Purinecarbonitriles by Pd(0)-Catalysed Coupling of Halopurines with Zinc Cyanide. , 1996 .

[20]  Sébastien Maignan,et al.  Molecular structures of human factor Xa complexed with ketopiperazine inhibitors: preference for a neutral group in the S1 pocket. , 2003, Journal of medicinal chemistry.

[21]  P. Dean,et al.  Molecular recognition: 3d surface structure comparison by gnomonic , 1987 .

[22]  R. Cherney,et al.  Mild and general methods for the palladium-catalyzed cyanation of aryl and heteroaryl chlorides. , 2007, Organic letters.

[23]  Nigel Greene,et al.  Physicochemical drug properties associated with in vivo toxicological outcomes: a review , 2009, Expert opinion on drug metabolism & toxicology.

[24]  M. Beller,et al.  A new palladium catalyst system for the cyanation of aryl chlorides , 2001 .

[25]  B. Jiang,et al.  Synthesis of dialkyl cyanoboronates and their application in palladium-catalyzed cyanation of aryl halides , 2001 .

[26]  M. Beller,et al.  A new palladium catalyst system for the cyanation of aryl chlorides with K4[Fe(CN)6] , 2007 .

[27]  S. Buchwald,et al.  Expanding Pd-catalyzed C-N bond-forming processes: the first amidation of aryl sulfonates, aqueous amination, and complementarity with Cu-catalyzed reactions. , 2003 .

[28]  Anna Gaulton,et al.  Drug target central , 2009, Expert opinion on drug discovery.

[29]  N. Pilpel.  The Effect of Solvent in Dipole Moment Measurements , 1955 .

[30]  D. Roe,et al.  Mechanisms of catalyst poisoning in palladium-catalyzed cyanation of haloarenes. remarkably facile C-N bond activation in the [(Ph3P)4Pd]/[Bu4N]+ CN- system. , 2008, Journal of the American Chemical Society.

[31]  G. Allan,et al.  Synthesis and SAR of novel hydantoin derivatives as selective androgen receptor modulators. , 2006, Bioorganic & medicinal chemistry letters.

[32]  D I Stuart,et al.  Binding of the Second Generation Non-nucleoside Inhibitor S-1153 to HIV-1 Reverse Transcriptase Involves Extensive Main Chain Hydrogen Bonding* , 2000, The Journal of Biological Chemistry.

[33]  Duane D. Miller,et al.  Structural basis for antagonism and resistance of bicalutamide in prostate cancer , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[34]  H. Ochiai,et al.  Synthesis and biological evaluation of dihydrofuran-fused perhydrophenanthrenes as a new anti-influenza agent having novel structural characteristic. , 2007, Bioorganic & medicinal chemistry.

[35]  Alterman,et al.  Fast microwave-assisted preparation of aryl and vinyl nitriles and the corresponding tetrazoles from organo-halides , 2000, The Journal of organic chemistry.

[36]  F. Montanari,et al.  ChemInform Abstract: PHASE‐TRANSFER CATALYSIS IN THE NICKEL‐CATALYZED CYANATION OF ARYL HALIDES , 1979, Chemischer Informationsdienst.

[37]  S. Buchwald,et al.  A High-Yield, General Method for the Catalytic Formation of Oxygen Heterocycles , 2000 .

[38]  P. Kenny,et al.  Toward prediction of alkane/water partition coefficients. , 2008, Journal of medicinal chemistry.

[39]  J. Williams,et al.  1-amino-4-benzylphthalazines as orally bioavailable smoothened antagonists with antitumor activity. , 2009, Journal of medicinal chemistry.

[40]  Andreas Martin,et al.  Eco-friendly synthesis of p-nitrobenzonitrile by heterogeneously catalysed gas phase ammoxidation , 2002 .

[41]  M. Beller,et al.  Progress in the palladium-catalyzed cyanation of aryl chlorides. , 2003, Chemistry.

[42]  A. Bergamini,et al.  Specific targeting highly conserved residues in the HIV-1 reverse transcriptase primer grip region. Design, synthesis, and biological evaluation of novel, potent, and broad spectrum NNRTIs with antiviral activity. , 2005, Journal of medicinal chemistry.

[43]  Tracey Clark,et al.  Design of selective, ATP-competitive inhibitors of Akt. , 2010, Journal of medicinal chemistry.

[44]  M. Beller,et al.  A convenient and efficient procedure for the palladium-catalyzed cyanation of aryl halides using trimethylsilylcyanide , 2003 .

[45]  Catherine Burt,et al.  Novel indazole non-nucleoside reverse transcriptase inhibitors using molecular hybridization based on crystallographic overlays. , 2009, Journal of medicinal chemistry.

[46]  Christopher A. Lipinski,et al.  Chapter 27. Bioisosterism in Drug Design , 1986 .

[47]  R. Corbau,et al.  Optimization of 5‐Aryloxyimidazole Non‐Nucleoside Reverse Transcriptase Inhibitors , 2008, ChemMedChem.

[48]  P. Leeson,et al.  The influence of drug-like concepts on decision-making in medicinal chemistry , 2007, Nature Reviews Drug Discovery.

[49]  Eric Westhof,et al.  Halogen bonds in biological molecules. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[50]  H. van de Waterbeemd,et al.  Property-based design: optimization of drug absorption and pharmacokinetics. , 2001, Journal of medicinal chemistry.

[51]  Makoto Shimazaki,et al.  Einführung der Cyano-Gruppe in Pyrazine , 1981 .

[52]  Dafydd R Owen,et al.  Rapid assessment of a novel series of selective CB(2) agonists using parallel synthesis protocols: A Lipophilic Efficiency (LipE) analysis. , 2009, Bioorganic & medicinal chemistry letters.

[53]  Stefan Güssregen,et al.  Evidence for C-Cl/C-Br...pi interactions as an important contribution to protein-ligand binding affinity. , 2009, Angewandte Chemie.

[54]  T. Sandmeyer.  Ueber die Ersetzung der Amid‐gruppe durch Chlor, Brom und Cyan in den aromatischen Substanzen , 1884 .

[55]  K. Rosenmund,et al.  Das am Ringkohlenstoff gebundene Halogen und sein Ersatz durch andere Substituenten. I. Mitteilung: Ersatz des Halogens durch die Carboxylgruppe , 1919 .

[56]  E. Pai,et al.  An Extremely Potent Inhibitor of Xanthine Oxidoreductase , 2003, The Journal of Biological Chemistry.

[57]  L. Cassar.  A NEW NICKEL-CATALYZED SYNTHESIS OF AROMATIC NITRILES , 1973 .

[58]  L. Lin,et al.  A facile microwave-assisted palladium-catalyzed cyanation of aryl chlorides , 2006 .

[59]  M. Beller,et al.  A convenient procedure for the palladium-catalyzed cyanation of aryl halides. , 2003, Angewandte Chemie.

[60]  D. Tschaen,et al.  An Improved Procedure for Aromatic Cyanation , 1994 .

[61]  D. Willock,et al.  Polarizability anisotropies of cyano-substituted azulene, biphenyl, 2,2'- bipyridyl and naphthalene , 1999 .

[62]  S. Buchwald,et al.  Pd-catalyzed Suzuki–Miyaura reactions of aryl halides using bulky biarylmonophosphine ligands , 2007, Nature Protocols.

[63]  M. Beller,et al.  Palladium‐Catalyzed Cyanation of Aryl Halides: Recent Developments and Perspectives , 2003 .

[64]  S. Buchwald,et al.  The Palladium-Catalyzed Trifluoromethylation of Aryl Chlorides , 2010, Science.